ORM2 can bind with microglial C-C chemokine receptor type 5 (CCR5) and block the chemokine C-X-C motif ligand (CXCL)-4–CCR5 interaction that is critical for microglial activation to exert anti-inflammatory effects during brain inflammation [106]. This evidence concerns the gene CCR5 and brain inflammatory disease.